89 related articles for article (PubMed ID: 23913824)
1. Novel mutations and expression alterations in SMAD3/TGFBR2 genes in oral carcinoma correlate with poor prognosis.
Sivadas VP; George NA; Kattoor J; Kannan S
Genes Chromosomes Cancer; 2013 Nov; 52(11):1042-52. PubMed ID: 23913824
[TBL] [Abstract][Full Text] [Related]
2. The early manifestation, tumor-specific occurrence and prognostic significance of TGFBR2 aberrant splicing in oral carcinoma.
Sivadas VP; Gulati S; Varghese BT; Balan A; Kannan S
Exp Cell Res; 2014 Sep; 327(1):156-62. PubMed ID: 24846200
[TBL] [Abstract][Full Text] [Related]
3. Novel TGFBR2 and known missense SMAD3 mutations: two case reports of thoracic aortic aneurysms.
Panesi P; Foffa I; Sabina S; Ait Ali L; Andreassi MG
Ann Thorac Surg; 2015 Jan; 99(1):303-5. PubMed ID: 25555948
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.
Goggins M; Shekher M; Turnacioglu K; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 1998 Dec; 58(23):5329-32. PubMed ID: 9850059
[TBL] [Abstract][Full Text] [Related]
5. Mutational analysis of transforming growth factor-beta receptor type II and Smad3 tumor suppressor genes in prolactinomas.
Ikeda H
Brain Tumor Pathol; 2006 Apr; 23(1):7-12. PubMed ID: 18095113
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
7. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue.
Kim YJ; Hwang SJ; Bae YC; Jung JS
Stem Cells; 2009 Dec; 27(12):3093-102. PubMed ID: 19816956
[TBL] [Abstract][Full Text] [Related]
8. miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.
Li J; Liang H; Bai M; Ning T; Wang C; Fan Q; Wang Y; Fu Z; Wang N; Liu R; Zen K; Zhang CY; Chen X; Ba Y
PLoS One; 2015; 10(6):e0130194. PubMed ID: 26061281
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
10. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of miR-145 expression in oral squamous cell carcinomas and its clinical significance.
Gao L; Ren W; Chang S; Guo B; Huang S; Li M; Guo Y; Li Z; Song T; Zhi K; Huang C
Onkologie; 2013; 36(4):194-9. PubMed ID: 23548968
[TBL] [Abstract][Full Text] [Related]
12. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma.
Kozaki K; Imoto I; Pimkhaokham A; Hasegawa S; Tsuda H; Omura K; Inazawa J
Cancer Sci; 2006 Dec; 97(12):1351-8. PubMed ID: 17052259
[TBL] [Abstract][Full Text] [Related]
13. Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers.
Yamashita S; Takahashi S; McDonell N; Watanabe N; Niwa T; Hosoya K; Tsujino Y; Shirai T; Ushijima T
Cancer Res; 2008 Apr; 68(7):2112-21. PubMed ID: 18381416
[TBL] [Abstract][Full Text] [Related]
14. Genetic alterations of the TGF-beta signaling pathway in colorectal cancer cell lines: a novel mutation in Smad3 associated with the inactivation of TGF-beta-induced transcriptional activation.
Ku JL; Park SH; Yoon KA; Shin YK; Kim KH; Choi JS; Kang HC; Kim IJ; Han IO; Park JG
Cancer Lett; 2007 Mar; 247(2):283-92. PubMed ID: 16828225
[TBL] [Abstract][Full Text] [Related]
15. Amplification and up-regulation of microRNA-30b in oral squamous cell cancers.
Shao C; Yu Y; Yu L; Pei Y; Feng Q; Chu F; Fang Z; Zhou Y
Arch Oral Biol; 2012 Aug; 57(8):1012-7. PubMed ID: 22542163
[TBL] [Abstract][Full Text] [Related]
16. Susceptible genes and molecular pathways related to heavy ion irradiation in oral squamous cell carcinoma cells.
Fushimi K; Uzawa K; Ishigami T; Yamamoto N; Kawata T; Shibahara T; Ito H; Mizoe JE; Tsujii H; Tanzawa H
Radiother Oncol; 2008 Nov; 89(2):237-44. PubMed ID: 18514338
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of TGFBR2 mutations in Marfan-syndrome-related disorders suggests a correlation between phenotypic severity and Smad signaling activity.
Horbelt D; Guo G; Robinson PN; Knaus P
J Cell Sci; 2010 Dec; 123(Pt 24):4340-50. PubMed ID: 21098638
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
[TBL] [Abstract][Full Text] [Related]
19. Tgf-beta signaling alterations and colon cancer.
Bellam N; Pasche B
Cancer Treat Res; 2010; 155():85-103. PubMed ID: 20517689
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of transforming growth factor beta receptor type III in hepatocellular carcinoma is not directly associated with genetic alterations or loss of heterozygosity.
Bae HJ; Eun JW; Noh JH; Kim JK; Jung KH; Xie HJ; Park WS; Lee JY; Nam SW
Oncol Rep; 2009 Sep; 22(3):475-80. PubMed ID: 19639191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
